Rajan Sharma
Stock Analyst at Goldman Sachs
(0.07)
# 4,482
Out of 5,182 analysts
5
Total ratings
25%
Success rate
-42.45%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rajan Sharma
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reinstates: Sell | $7.25 | $19.79 | -63.37% | 1 | May 29, 2025 | |
| AZN AstraZeneca | Initiates: Buy | $97 | $189.75 | -48.88% | 1 | May 30, 2024 | |
| GSK GSK plc | Initiates: Neutral | $47 | $54.44 | -13.67% | 1 | May 30, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $29.30 | +169.62% | 2 | Jun 20, 2023 |
DBV Technologies
May 29, 2025
Reinstates: Sell
Price Target: $7.25
Current: $19.79
Upside: -63.37%
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $189.75
Upside: -48.88%
GSK plc
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $54.44
Upside: -13.67%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $29.30
Upside: +169.62%